newsnoon

The recent FDA approval of the Neffy epinephrine nasal spray marks a significant milestone in the world of allergy treatment. As the first non-injectable emergency treatment for allergies, Neffy offers a convenient and user-friendly alternative to traditional injectable epinephrine products. Administered as a single-dose nasal spray, Neffy is a game-changer in the treatment of type
0 Comments
The Federal Reserve Bank of New York recently reported that Americans now owe a record $1.14 trillion on their credit cards, with the average balance per consumer standing at $6,329. This represents a 4.8% increase year over year, according to a separate quarterly credit industryinsights report from TransUnion. It is evident that credit card debt
0 Comments
A recent retrospective cohort study conducted by Cindy X. Cai, MD, and colleagues at the Wilmer Eye Institute revealed a concerning trend in the severity of rhegmatogenous retinal detachment (RRD) among individuals with adverse social determinants of health. The study, which included 700 patients who underwent primary repair of uncomplicated RRD, found that patients living
0 Comments